Well 2024 was always promised to be ADR's year.. Dr. Paul...

Well 2024 was always promised to be ADR's year..

Dr. Paul Mastoridis is certainly in place to bring ADR to serious global attention..

Considering we are in a better position than we have ever been regarding global exposure, incoming revenue and now :
Highlights:
• Hailie® Smartinhaler® has received clearance from the U.S. Food and Drug Administration (FDA) for use with AstraZeneca's Airsupra® and Breztri® inhalation devices.
• Airsurpa® and Breztri®, developed by AstraZeneca®, are at the forefront of respiratory care.
• This new compatibility with Breztri® gives Adherium 100% coverage for triple therapy inhalers in the US.

SP should be traveling around 15-20cents IMO, but obviousily it will fall back to 5 cents, you wait and see... however due to ADR being so quiet for so long, the true re-rate is going to take a moment for the markets to absorb the story here.. You also have to understand many shareholders will simply be happy to get their money back and move on, common in this game for those that have been in the red for so long..

The run to 9 cents today was encouraging, just need the SP to continue to consolidate along with ADR to release ongoing updates and encouraging news.. Personally Dr. Paul Mastoridis seem to have taken the reigns of ADR and steering us in the right direction, especially with his high-end contacts in this industry..

This is going to one day have a mass increase the day the revenue figures start making serious jumps each QTR... what we need to realize is that our revenue is only going to increase each QTR, so therefore the SP will and should correspond accordingly.. Hopefully the marketing boys in ADR know how to promote what is going on here at ADR... ongoing updates and media exposure is a must..

There is nothing stopping ADR gaining mass traction from here moving forward... its all about the revenue now.. ADR has now achieved everything that is needed to now increase ongoing revenue and ongoing global exposure... its all about time now... something tells me Dr. Paul Mastoridis is not sitting on idle hands as alike our last CEO... 2024 could prove the re-rate we long termers have all been hoping for..

SP will only become seriously stable the moment revenue is secure... for now we will be subject to drastic SP swings... IMO we are way undervalued now, Dr. Paul Mastoridis has his work cut out for him, but Im feeling confident this is the man to achieve greatness for this company... 12 months from now I am expecting to see the SP to be minimal of 5X current SP... lets go ADR... time to shine